Report Categories
View AllRecent Articles
View All
Qualcomm Surges as Investor Optimism Grows Over AI Device Boom
Tesla Launches Full SelfDriving Supervised in China After Lengthy Regulatory Hurdles
Nvidias Blockbuster Quarter CEO Huang Concedes China Market Highlights 200 Billion Edge Computing Opportunity
AUTO1 Group SE Reports Voting Rights Change Under German Securities Law
Safepoint Insurance Targets 116 Billion Valuation in Upcoming US IPO
BARK Inc Q1 2026 Earnings Losses Narrow More Than Expected Amid Cost Discipline
BBB Foods Inc TBBB Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Quarter
Sequans Communications Q1 2026 Earnings A Wide EPS Miss Met With a Surprising Stock Rally
SCNX Q1 2026 Earnings Significant EPS Beat Despite Lack of Revenue
LWAY Q1 2026 Earnings EPS Falls Just Short of Estimates Stock Slightly Lower
Sally Beauty Holdings SBH Inches Higher as Stock Consolidates Near Key Levels
Galectin Therapeutics Slips 3 as Stock Nears Key 257 Support Level
Roma Green Finance Limited ROMA Rises 145 as Stock Holds Above Key Support
WORK Medical Technology WOK Experiences Continued Decline Falls 541 to 010
SP 500 MeltUp Scenario Could Index Surge to 8000
SpaceX Scrubs Starship Test Flight Targets Friday Launch for V3 Debut
Humana Shares Decline After Medicare Advantage Rate Disappoints
AnheuserBusch InBev Shares Dip as Quarterly Sales Miss Market Expectations
External Links
Tesla Surpasses Profit Expectations Despite Revenue Miss as Auto Margins Improve
Great Elm Group Inc Q1 2026 Earnings Significant EPS Miss Amid Revenue Uncertainty
Gladstone Land Preferred Stock LANDO Holds Near Support Amid Modest Decline
Vuzix Corporation VUZI Surges 9 as Stock Tests Key Resistance at 540
Presidio Property Trust Series A SQFTW Trades Flat at 002 Amidst Thin Liquidity
Ponce Financial Group PDLB Holds Steady Near Resistance as Uptrend Shows Resilience
Aclaris Therapeutics ACRS Edges Lower Amid Tight Trading Range
BRC Group Senior Notes RILYN Hold Firm at 2486 as Bond Market Sentiment Stabilizes
Qiagen QGEN Rebounds from Support Tests Key Resistance Zone
Royalty Pharma RPRX Edges Higher Testing Resistance Near 57 Amid Steady Gains